Anton Pozniak

发表

Positive and Negative drug Selection Pressures on the N348I Connection Domain Mutation: New Insights from in vivo Data

David Dunn, Huw Price, Deenan Pillay, 2010, Antiviral therapy.

Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions

Samantha J Lycett, Manon Ragonnet-Cronin, Stéphane Hué, 2014, AIDS.

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

John P. Walsh, Andrew N. Phillips, Steve Kaye, 2007, AIDS.

Current Opinion in Infectious Diseases: Editorial introductions

Martin Fisher, Anton Pozniak, Thomas F. Patterson, 2010 .

The impact of HIV prevalence, conflict, corruption, and GDP/capita on treatment cascades: data from 137 countries

Anton Pozniak, A. Pozniak, Jacob Levi, 2018, Journal of virus eradication.

Surrogacy in HIV-1 clinical trials

Anton Pozniak, A. Pozniak, 1998, The Lancet.

The UK Register of HIV Seroconverters: methods and analytical issues

Andrew N. Phillips, Kholoud Porter, Am Johnson, 1996, Epidemiology and Infection.

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.

David Dunn, Kholoud Porter, Rodolphe Thiébaut, 2011, The Lancet. Infectious diseases.

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

Terri Wrin, Josephine Birungi, Dennis R. Burton, 2009, Journal of Virology.